Cyclodextrin-bound silicone materials and their use as carriers for actives
The cyclodextrin modified through silylation reaction is compatible with the silicone matrix, which solves the problem of incompatibility between cyclodextrin and silicone in the prior art, simplifies the preparation process and improves the material properties, and realizes the active substances effective release control.
Patent Information
- Application Number
- CN202280095350.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-25
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art is difficult to produce silicone-compatible cyclodextrins without using additional compatibilizers, resulting in complex preparation process of silicone materials, high cost and uneven product performance.
The cyclodextrin is modified by silylation reaction to compatible with the silicone matrix to form a curable silicone rubber composition that encapsulates and controls the release of the active substance.
The compatibility of cyclodextrin and silicone matrix is achieved, the use of organic solvents is reduced, the preparation process is simplified, and the uniformity and performance of the material is improved, so that the release of active substances can be effectively controlled in different applications.
Smart Images

Figure CN119072531A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to cyclodextrins as part of silicone compositions and their use in forming articles for absorbing, encapsulating and delivering actives and other compounds. Examples of such articles may be transdermal patches, pressure-sensitive adhesives, medical devices, films, gels, clothing or other wearable materials, etc. The cyclodextrins should be compatible with the silicone matrix even without the use of any additional compatibilizers. The present invention can be used in a variety of applications, including cosmetics, medical, home care, textiles, industry and other applications.
[0002] The use of silicone-compatible cyclodextrins is useful in applications such as controlled, delayed or extended, release, on-demand, and triggered release of active materials. Background Art
[0003] Prior art
[0004] In the prior art, the reaction of rubber or silicone rubber with modified cyclodextrins has been described.
[0005] US 5,391,592 describes silicone elastomers for contact lens applications by using an olefin-modified cyclodextrin (CD) to react with a SiH-containing silicone via a hydrosilylation reaction to produce a lipophilic CD-silicone polymer. The encapsulation and release of active substances from the elastomer is not taught in this patent. Furthermore, simply, the lipophilicity of the CD does not necessarily make it compatible with silicone. Therefore, forming an elastomer by using only hydrophilic or lipophilic CDs would require special conditions, such as the use of additional compatibilizers (e.g., solvents, high temperatures, etc.). Therefore, in the examples of 592, toluene is used as a solvent to bring the different components (cyclodextrin and silicone) into the same phase for the hydrosilylation reaction required to produce the elastomeric material for the contact lens. The use of additional solvents would generate additional manufacturing costs due to the special handling required as well as environmental and health issues.
[0006] US 7,235,186 B2 describes the attachment of cyclodextrins to silicones by condensation reactions. However, a specific type of cyclodextrin must be used, namely CD functionalized with halogenated triazines, epoxy groups, amino groups, vinylsulfonyl groups, acryl- or methacryloyl groups. Particularly functionalized cyclodextrins are expensive. Products from this process will have limited applicability. For example, they are not suitable for RTV-2 type rubbers. The presence of some functional groups such as nitrogen-containing amines or triazine groups may also interfere with certain curing methods, for example they will interfere with platinum catalysts used for the curing of some rubbers. The compatibility of cyclodextrin-modified silicones with other silicones is not mentioned. The 186 patent also describes crosslinkable silicone compositions based on organosilicon compounds containing cyclodextrin groups. The silicones and cyclodextrin-modified silicones or silanes described are not expected to be compatible and react in a homogeneous phase. Therefore, crosslinking is preferably carried out in the form of an emulsion with an additional emulsifier. In addition to increasing the cost, in many applications, the presence of an additional emulsifier can adversely affect the desired properties. Furthermore, in many applications, leaching of the emulsifiers creates problems. The crosslinking is based on a condensation reaction and requires temperatures above 100°C.
[0007] Materials Science and Engineering C 28 (2008) 705-715 describes the synthesis of silicone with β-cyclodextrin, however, the synthesis involves multiple steps. β-cyclodextrin is chemically grafted onto a poly(methylhydrogenated siloxane) polymer or a poly(methylhydrogenated siloxane-co-dimethylsiloxane) copolymer by hydrosilylation. The multi-step synthesis includes regioselective attachment of a tosyl group to a primary hydroxyl group, conversion to an allyl derivative, and subsequent acetylation of the remaining hydroxyl groups. The final step is to graft the cyclodextrin derivative onto the silicone polymer by hydrosilylation. The method involves too many steps and is therefore likely to be expensive and lacks the simplicity required for industrial production. The monoallyl peracetylated β-cyclodextrin derivative used is not siloxane compatible. A large excess of the flammable and toxic solvent toluene must be used as a solvent for chemically bonding the cyclodextrin derivative to a silicone polymer. The product is not a cross-linked silicone rubber.
[0008] DE 4324636 describes the modification of alkenyl-functional cyclodextrins with hydrogen-functionalized polysiloxanes by hydrosilylation and their immobilization in support materials for chromatographic separations. Here too, large amounts of solvents such as toluene must be used for the reaction between CD and water-functionalized silicones, since the cyclodextrins used are not compatible with silicones. The CD-modified silicones mentioned in this patent are not elastomeric. There is no teaching of the use of these materials for the controlled release of active substances.
[0009] CN 102019171 describes a solid phase microextraction coating, characterized in that the solid phase microextraction coating comprises beta-cyclodextrin and polydimethylsiloxane bonded to each other. There is no teaching on the suitability of the material for controlled release.
[0010] US 9492549 points out the possible use of cyclodextrin as a hydrophilic component to promote the release of silver salts from an antimicrobial composition comprising alkenyl- and / or alkynyl-substituted polysiloxanes, at least one polysiloxane comprising silicon-bonded hydrogen atoms and at least one hydrosilylation catalyst. Cyclodextrins are incompatible and not chemically bonded with silicones and are expected to result in phase separation without the use of any other compatibilizers. Phase separation may result in poor performance of the final product.
[0011] EP 1206290 B1 describes a pressure-sensitive adhesive composition containing cyclodextrins. Although it is mentioned that the adhesive can be based on silicone gel (which is not the same as cross-linked silicone polymers), the cyclodextrins used are in the form of hydrocolloids and they are not silicone compatible. If they need to be made compatible with silicone, they will require additional compatibilizers.
[0012] US 6851462 B2 describes a rubber composition containing cyclodextrins or substituted or derivatized cyclodextrins that are compatible with rubber. Silicone rubber is not part of the rubber. Silicone provides advantages such as breathability, biocompatibility, and reduced skin adhesion trauma. The compatibility of cyclodextrins with silicone rubbers is not taught in this patent; therefore, these rubbers lack the beneficial advantages provided by silicone.
[0013] US 4978532 describes a medical grade silicone pressure sensitive adhesive DHEA and hydroxypropyl-β-cyclodextrin as a penetration enhancer. Cyclodextrin is incompatible in silicone and is therefore expected to result in inhomogeneities in the absence of other compatibilizers.
[0014] The uniformity of the rubber composition is important before and / or after curing because of the ease of processability and the proper maintenance of the desired properties. Heterogeneous mixtures are difficult to handle because all components are not evenly distributed. The non-uniformly cured elastomer will have defective points caused by the points or regions of heterogeneity, which will adversely affect its mechanical and other properties. Therefore, in the prior art, additional compatibilizers and solvents are used to make the composition uniform. But this increases inconvenience, danger and cost. For example, if often flammable organic solvents are used, it is necessary to ensure a special processing environment. Therefore, it is desirable to avoid this situation.
[0015] All of the above-mentioned prior art, either alone or in combination, fail to solve the problem of producing silicone materials comprising cyclodextrins in a simple and efficient manner. Summary of the invention
[0016] It is therefore an object of the present invention to provide a product and method for encapsulation and controlled release of actives from a silicone matrix (e.g. silicone elastomer, silicone PSAs (pressure sensitive adhesives) etc.) which incorporates cyclodextrins and wherein such cyclodextrins are compatible with the silicone matrix and wherein the cyclodextrin cavities remain available for encapsulation and delivery of different active materials.
[0017] The object of the present invention is silicone-compatible cyclodextrins or derivatives thereof which are part of a silicone matrix and which use such cyclodextrins to encapsulate actives in their cavities and release them according to the desired needs. Such cyclodextrin derivatives of the present invention are compatible with the silicone matrix and thus the amount of organic solvents can be minimized or avoided.
[0018] In order not to overload the description of the present invention with pages, only preferred embodiments of individual features are indicated for each component.
[0019] Those skilled in the art will expressly understand that a disclosure of this type means that every combination of varying degrees of preference is expressly disclosed and considered to be expressly contemplated; ie, any combination within a single component and between different components.
[0020] The present invention provides a curable silicone rubber composition comprising
[0021] - 20 wt% to 99.9 wt% of a silicone matrix, and
[0022] - 0.1 wt% to 80 wt% of at least one cyclodextrin (CD) modified by a silylation reaction to contain a silyl group of formula (1)
[0023] -(OSi(R 1 )3) x (1)
[0024] The condition is
[0025] R 1 are independently identical or different alkyl-, alkylene-, aryl- or alkyl-substituted aryl groups, carbonyl; and
[0026] x is a number from 1 to 96
[0027] 0 to 50% by weight of at least one active substance (=guest molecule), always based on the total silicone rubber composition, with the proviso that all components always add up to 100% by weight.
[0028] The preferred amount is 50-95 wt% of the silicone matrix and 0.1-60 wt% of at least one of the modified cyclodextrins containing silyl groups of formula (1). More preferred is 70-95 wt% of the silicone matrix and 0.1-50 wt% of at least one of the cyclodextrins (CD) containing silyl groups of formula (1).
[0029] If the silicone rubber composition contains any active material, the amount used is preferably 0.1-50 wt%, more preferably 0.1-30 wt%.
[0030] All of the above preferred amounts are with the proviso that all components always add up to 100 wt%.
[0031] Silyl-modified cyclodextrin
[0032] In formula (1)
[0033] R 1 The alkyl group is preferably a methyl group, an ethyl group, a propyl group, or an isobutyl group; more preferably a methyl group and an ethyl group, and most preferably a methyl group.
[0034] R 1 The alkylene group is preferably vinyl, propylene or isobutylene, and more preferably vinyl.
[0035] R 1 The aryl group as an aryl group or an alkyl group substituted aryl group is preferably a phenyl group and a formyl group; more preferably a phenyl group.
[0036] R 1 It is preferably selected from the group consisting of methyl, ethyl, vinyl and phenyl.
[0037] x is preferably a number of 1-30, and more preferably 1-24.
[0038] An advantage of the present invention is that the cyclodextrins of the present invention are compatible with the silicone matrix and therefore no significant inhomogeneities or phase separations occur.
[0039] The cyclodextrins of the present invention are compatible with silicone matrices because the cyclodextrins (CDs) are very specifically modified with short silyl groups (e.g., trimethylsilyl, vinyldimethylethylsilyl, etc.) by a silylation reaction. These modified CDs can be incorporated into silicone compositions by standard mixing techniques, such as magnetic stirring, homogenization, rapid mixing, etc. at room temperature or in some cases by heating.
[0040] In this silylation reaction, the alcohol group from CD is silylated. The method includes replacing the proton with, for example, a trialkylsilyl group, typically trimethylsilyl (-SiMe3). In a typical method, the substrate is deprotonated with a suitable strong base such as butyl lithium or a Grignard reagent and then treated with a silyl chloride. Preferred silyl chlorides are chlorotrimethylsilane, chlorodimethylvinylsilane and phenyldimethylchlorosilane. In place of silyl chlorides, it is further preferred to use bis(trimethylsilyl)amine (=hexamethyldisilazane=HMN) and bis(vinyldimethylsilyl)amine (VMN).
[0041] The following scheme shows the reaction of a commercially available cyclodextrin (CD-OH) (e.g., W7 or W8, from Wacker Chemie AG, Germany) to prepare the silicone-compatible cyclodextrins of the present invention.
[0042]
[0043] A variety of silyl functional groups can be used for silylation. For example, the silyl group can contain alkyl, alkenyl, aryl, aralkyl, carbonyl, etc.
[0044] The silyl-modified cyclodextrin may be present as a non-reactive component (eg, in the case of trimethylsilyl-modified CDs) or may be chemically bound to the silicone matrix (eg, in the case of vinyldimethylsilyl-modified CDs).
[0045] Silicone matrix
[0046] The silicone matrix can be produced by standard state of the art chemistry for making such materials, such as RTV-2, RTV-1, those produced by hydrosilylation, free radical, anionic, cationic or condensation polymerization, UV or other high energy radiation, thiol-ene click chemistry, and the like.
[0047] Although long known in the art, a brief description of some of these suitable silicone compositions is given here.
[0048] Addition crosslinking silicone composition
[0049] Addition-crosslinking silicone compositions have long been known to those skilled in the art. In the simplest case, an addition-crosslinking silicone composition comprises at least one organopolysiloxane having at least two aliphatic unsaturated groups in the molecule (e.g. aliphatic unsaturated groups, Si-bonded vinyl groups) and at least one organohydrogenpolysiloxane having two or more SiH groups in the molecule and at least one catalyst which promotes the addition of Si-bonded hydrogen to aliphatic multiple bonds, which is also described as a hydrosilylation catalyst. The consistency of the addition-crosslinking silicone composition can be adjusted so that HTV (high temperature vulcanization), LSR (liquid silicone rubber) and also RTV (room temperature vulcanization) silicone elastomers can be produced. These can be one-, two- or multi-component compositions.
[0050] Condensation cross-linked silicone composition
[0051] Condensation crosslinking silicone compositions have long been known to those skilled in the art. Common embodiments of condensation crosslinking silicone compositions have the names RTV-1 (1-component) and RTV-2 (2-component). RTV-2 compounds typically contain at least one organopolysiloxane with terminal silanol groups in one component and other components such as fillers and plasticizers. The second component (curing agent) contains a combination of a crosslinking agent silane or siloxane with a catalyst that accelerates the condensation reaction and optionally other components such as a plasticizer. As crosslinking agent silane or siloxane, silanes and siloxanes with at least three hydrolyzable groups are mainly used. When curing into atmospheric moisture, the condensation crosslinking RTV-1 compound gives a silicone elastomer in the form of a hydrolysis product, which is based on the ability to use a crosslinking agent containing multiple hydrolyzable groups to end-cap the terminal hydroxyl organopolysiloxane without simultaneously initiating a crosslinking reaction. As a crosslinking agent, all silanes or partial hydrolysis products thereof with at least three hydrolyzable groups can be used. In order to achieve sufficiently high crosslinking rates, most RTV-1 compounds contain condensation catalysts, for example organotin and organotitanium compounds or mainly metal compounds of Group I and Group II.
[0052] Peroxide-induced cross-linked silicone compositions
[0053] These compositions have also been known to the person skilled in the art for a long time. In the simplest case, peroxide-induced crosslinking silicone compositions comprise at least one organopolysiloxane having at least 2 crosslinkable groups per molecule (e.g. methyl or vinyl groups) and at least one suitable organic peroxide catalyst. They are usually produced as HTV compounds.
[0054] Light-induced cross-linked silicone compositions
[0055] These compositions have also been known to the person skilled in the art for a long time.Depending on the reaction mechanism, the light-induced crosslinking silicone compositions comprise at least one photoactivatable initiator or catalyst.
[0056] Furthermore, all of the above-mentioned silicone compositions according to the invention may contain further additives (W), which are also previously known for use in their production, such as, for example, reinforcing fillers, non-reinforcing fillers, fungicides, fragrances, rheological additives, corrosion inhibitors, oxidation inhibitors, light stabilizers, heat stabilizers, flame retardants, agents for influencing electrical properties, dispersant additives, solvents, adhesion promoters, pigments, dyes, plasticizers, organic polymers, solvents, and the like.
[0057] Addition-curable silicone compositions are preferred as silicone matrices.
[0058] Active substances
[0059] Active substances are guest molecules that can be encapsulated in the cavity of a cyclodextrin molecule (complex). Guest molecules can include drugs, drug products, cosmetics or personal care or health actives, biocides, insecticides, fungicides, herbicides, pheromones, fragrances, flavorings, pigments, pharmaceutically active compounds, natural or other oils, antigens, active compounds for antistatic finishes or flame retardant finishes, stabilizers (UV), dyes, odor causing molecules, etc., or a combination of two or more.
[0060] Guest molecules (=active substances) can be incorporated into the cyclodextrins before, during or after formation of the silicone matrix and can be released when necessary for the end use. The CDs of the invention can also be used to absorb molecules, such as odor-causing compounds and others when desired.
[0061] It is not a given that any CD will still be useful for encapsulation after silyl modification, as the cavity size and / or shape of the CD can be altered. However, we have found that complexation and release of guest molecules can still be achieved from a cured silicone elastomer into which a silylated CD has been incorporated.
[0062] The present invention further provides a process for producing the curable silicone rubber composition of the present invention by mixing all compounds by standard mixing techniques such as magnetic stirring, homogenization, rapid mixing, etc. at room temperature or by heating.
[0063] The present invention further provides a silicone product which is obtainable by filling the curable silicone rubber composition of the present invention into a form or applying it onto a surface and subsequently curing it.
[0064] When containing actives, such silicone products of the present invention can be used for the controlled, delayed or triggered release of such actives, for example in pharmaceutical applications, cosmetic applications, personal care applications, health applications, room fragrance applications, biocide applications, insecticide applications, fungicide applications, herbicide applications, textile applications.
[0065] Silicone products of the present invention as transdermal controlled release devices:
[0066] The transdermal patch containing the therapeutic component is constructed in the following manner: the component is mixed with the silylated CD to form a complex, the therapeutic component-CD complex is added to the adhesive elastomer cured silicone matrix, the film of the composition is drawn and cured to form a cured adhesive film, and the film is combined with various other layers (such as backing layer and release liner) usually found in the transdermal patch. The combination of the different layers of the patch can be completed using the standard method for making this type of patch, such as lamination. For the end user to use the patch, after removing the release liner, the patch is applied to the skin and pressure is applied until it sticks. The therapeutic component penetrates the skin into the blood stream in a controlled manner for a period of time that continues to extend. Suitable skin penetration enhancers can be used. These enhancers are known.
[0067] The silicone product of the present invention is used as an insect repellent belt:
[0068] Suitable silylated CDs can be mixed with an insect repellent component (e.g., DEET) to form a composite. The composite is incorporated into a curable silicone matrix for making a wearable insect repellent band. After the band is made, the insect repellent component is released from the band for an extended period of time, thereby providing longer protection for the user.
[0069] The silicone product of the present invention as a wearable beauty mask:
[0070] A wearable anti-aging mask can be constructed by forming a complex between silylated CD and an anti-aging active (e.g., retinol, glycolic acid, etc.), mixing the complex with an RTV-2 type curable silicone matrix, and molding the formulation into the form of a mask. During the use of the mask by the consumer, the complex slowly releases the anti-aging active over an extended period of time, thereby providing better efficacy of the active. This method can also be used to construct an under-eye patch to remove wrinkles.
[0071] The silicone product of the present invention with triggered release:
[0072] The active material can be complexed with the silyl-modified CD. The complex can be incorporated into a silicone matrix, and a device (e.g., a transdermal or topical patch) can be made with the silicone material. For example, the silicone material can be part of the adhesive component of the patch. The CD active complex is interrupted and releases activity by applying a suitable trigger. The trigger can be, for example, human body heat (normal or elevated human body temperature), body exudates (e.g., sweat, moisture, pH), mechanical forces (e.g., friction, chemical agents, other external irritants (e.g., light, blow-drying), water, heat, electricity; chemical agents and combinations thereof.
[0073] An embodiment of triggered release may be one in which the release is triggered by heat generated by using a supercooled solution in the patch. The supercooled solution may begin to solidify and generate heat. The solidification process may be initiated by an activator, such as by using activated crystals as described in US 6,103,139. The heat generated in this way may cause the decomplexation of the silyl-CD-active complex and release the active ingredient. Another embodiment of triggered release may be by using a chemical reagent that will bind more strongly to the silyl-CD and replace the original guest molecule that caused its release.
[0074] The silicone product of the present invention that is triggered to release by chemical heating method:
[0075] A chemical warming mechanism based on air activation of the oxidation of the substance can be used for decomplexation of the silyl-CD-active complex and release of the active ingredient. Such a heating mechanism is described in US2013 / 0006337A1. A mixture of iron powder, salt, water, activated carbon and an absorbent material is used, wherein oxygen reacts with the iron powder and the oxidation reaction releases heat. Heat generation by oxidation of the iron powder is used in many manual warmers available on the market, but in our invention this principle can be used to release the active ingredient from the silyl-CD-active complex.
[0076] The silicone product of the present invention, which is released by triggering an external heating device:
[0077] An embodiment of a triggered release may be where the release is triggered by heat generated by an external heating device, such as a battery or electrically operated handheld heating device, for example as described in US 2006 / 0142750 A1.
[0078] When containing no actives, such silicone products of the present invention may be used in applications to capture undesirable agents.
[0079] Silicone products of the present invention for capturing unwanted agents via silyl-CD:
[0080] Siloxane compatible CDs can be used to capture unwanted chemicals. For example, silyl CDs can be incorporated into a silicone elastomer matrix. During processing or use of the elastomer in a device, the cyclodextrin component can capture unwanted chemicals. For example, during the curing of the elastomer, the silyl-CDs can complex catalyst poisons that would otherwise adversely affect the curing process. Another example is that during use of the cured silicone material (e.g., as a film), the cavities of the initially empty silyl-CDs can bind odor-causing molecules.
[0081] The following examples illustrate the principle performance of the present invention without limiting the invention to the contents disclosed therein.
[0082] In the following examples, all parts and percentages are by weight unless otherwise indicated. Unless otherwise indicated, the following examples were carried out under ambient atmospheric pressure, i.e. at about 1000 hPa, and at room temperature, i.e. at about 20° C., or at room temperature in conjunction with the established temperature of the reactants without additional heating or cooling. DETAILED DESCRIPTION
[0083] Example
[0084] General conditions for preparing siloxane-compatible cyclodextrins: A 4-cold round-bottom flask equipped with various neck adapters and stopcock-joints to accommodate a mechanical stirrer, a thermocouple, an addition funnel, a water condenser, a nitrogen inlet and outlet, and a rubber septum was used for the synthesis of silylated cyclodextrins. A heating mantle was used to heat the flask. All glassware was pre-dried in an oven at 125° C. for at least 4 hours and cooled to room temperature before use. An electronic thermostat was used in conjunction with a thermocouple to control the heating of the flask and contents. The preparation was carried out under a gentle stream of dry nitrogen. Vacuum distillation was performed in a rotary evaporator equipped with a dry ice condenser. Filtration was performed by standard gravity filtration techniques or vacuum filtration techniques using a Buchner funnel.
[0085] Cyclodextrin (β-cyclodextrin (WACKER W7) or γ-cyclodextrin (WACKER W8)) is pre-dried as follows to remove absorbed moisture from the solid powder. The cyclodextrin is placed in a crystallization tray in an oven heated to 100°C for 16 hours. The tray is then removed from the oven and placed in a desiccator with a bottom lined with phosphorus pentoxide (P2O5) powder and allowed to cool to room temperature.
[0086] Synthesis of trimethylsilyl β-cyclodextrin CH62:
[0087] Beta-cyclodextrin (60.0g, 0.0529mol) is gradually added to a 1L four-necked glass flask containing 600g (7.59mol) of anhydrous pyridine, stirred continuously at 200rpm. The mixture is then stirred for 30 minutes to uniformly disperse the cyclodextrin. A slightly yellow and translucent dispersion is produced without large distinguishable solid particles. Then 71.7g (0.444mol) of bis(trimethylsilyl)amine (also referred to as hexamethyldisilazane or HMN) is added to the dispersion to produce an off-white, turbid and gelatinous slurry. 48.2g (0.444mol) of trimethylchlorosilane is added dropwise to the slurry via a glass addition funnel. Trimethylchlorosilane is added to convert the slurry into an opaque white dispersion. Heat release is noted immediately after adding trimethylchlorosilane. The reactor atmosphere was bubbled through a 3.7 wt. % solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that might be produced and drive the reaction to completion.
[0088] After the addition of trimethylchlorosilane was completed, the dispersion was stirred for another 65 minutes. The solvent was distilled out under vacuum until an off-white paste was left. The paste was then mixed with 375mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum to remove the solvent until a solid foam was formed. The solid foam was then cooled in a refrigerator set to -30°C, crushed into fine particles and dried in a vacuum oven at 55°C. The particles were cooled to room temperature, then crushed into fine powder with a mortar and pestle to obtain 112.7g of white fine powder. 1HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 17.5 trimethylsilyl (TMS) groups and an average of 3.5 OH groups.
[0089] Synthesis of trimethylsilyl γ-cyclodextrin CH48-2:
[0090] Under continuous stirring at 200rpm, gamma-cyclodextrin (60.0g, 0.0463mol) was gradually added to a 1L four-necked glass flask containing 600g (7.59mol) of anhydrous pyridine. The mixture was then stirred for 30 minutes to evenly disperse the cyclodextrin. A slightly yellow and translucent dispersion was produced with no large distinguishable solid particles. Then 70.9g (0.439mol) of WACKER SILAZANE HMN (bis(trimethylsilyl)amine) was added to the dispersion to increase turbidity. 50.3g (0.463mol) of trimethylchlorosilane was added dropwise to the dispersion via a glass addition funnel. Addition of trimethylchlorosilane formed an opaque white dispersion. An exotherm of about 20-25°C was noted immediately after the addition of trimethylchlorosilane. The reactor atmosphere was bubbled through a 3.7 wt. % solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that might be produced and drive the reaction to completion.
[0091] After the addition of trimethylchlorosilane was completed, the dispersion was stirred for an additional 65 minutes. The solvent was distilled off under vacuum until an off-white paste remained. The paste was then mixed with 375 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum until a solid foam was formed. The solid foam was then cooled in a freezer set to -30°C, crushed into fine particles and dried in a vacuum oven at 55°C for 16h. The particles were cooled to room temperature and then crushed into a fine powder with a mortar and pestle to obtain 125.8g of white fine powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 21.5 TMS groups and an average of 2.5 OH groups.
[0092] Synthesis of Vinyldimethylsilyl β-cyclodextrin CH70-2:
[0093] β-cyclodextrin (35.0 g, 0.0308 mol) was gradually added to a 1L four-necked glass flask containing 375 g (4.74 mol) of anhydrous pyridine and stirred continuously at 200 rpm. The mixture was then stirred for 30 minutes to uniformly disperse the cyclodextrin. A slightly yellow and translucent dispersion was produced with no large distinguishable solid particles. 42.0 g (0.227 mol) of WACKERSILAZANE VMN, bis (dimethylvinylsilyl) amine (also referred to as 1,1,3,3-tetramethyl-1,3-divinyldisilazane, or VMN) and 27.3 g (0.226 mol) of chlorodimethylvinylsilane were then loaded into a separate addition funnel. About 10-15% of bis (dimethylvinylsilyl) amine was then added dropwise (for about 1 minute), and chlorodimethylvinylsilane was then added dropwise. Both reagents were added dropwise simultaneously until completion. An exotherm was noted immediately after the addition of chlorodimethylvinylsilane. The addition of the silylating agent resulted in the formation of an opaque, off-white dispersion. The reactor atmosphere was bubbled through a 3.7 wt. % solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that may be produced and drive the reaction to completion.
[0094] After the addition of the silylating agent was completed, the dispersion was stirred for another 65 minutes. The solvent was distilled off under vacuum until an off-white paste was left. The paste was then mixed with 375 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum until a solid foam was formed. The solid foam was then cooled in a refrigerator set to -30 ° C, crushed into fine particles and dried in a vacuum oven at 60 ° C for 16 hours. The particles were cooled to room temperature, then crushed into fine powder with a mortar and pestle to obtain 68.0 g of white fine powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 17.3 VDMS and an average of 3.7 OH groups.
[0095] Synthesis of dimethylvinylsilyl γ-cyclodextrin CH61:
[0096] Gamma-cyclodextrin (60.0 g (0.0463 mol)) was gradually added to a 1 L four-necked glass flask containing 600 g (7.59 mol) of anhydrous pyridine under continuous stirring at 200 rpm. The mixture was then stirred for 30 minutes to evenly disperse the cyclodextrin. A slightly yellow and translucent dispersion was produced with no large distinguishable solid particles. 81.5 g (0.440 mol) of WACKER SILAZANE VMN, bis(dimethylvinylsilyl)amine, was then added to the dispersion to increase the turbidity. 55.8 g (0.462 mol) of chlorodimethylvinylsilane was added dropwise to the dispersion via a glass addition funnel. The addition of chlorodimethylvinylsilane formed an opaque white dispersion. An exotherm was noted immediately after the addition of chlorodimethylvinylsilane. The reactor atmosphere was bubbled through a 3.7 wt.% solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that may be produced and drive the reaction to completion.
[0097] After the addition of the silylating agent was completed, the dispersion was stirred for another 65 minutes. The solvent was distilled off under vacuum until an off-white paste remained. The paste was then mixed with 375 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum until a solid foam was formed. The solid foam was then cooled in a refrigerator set to -30°C, crushed into fine particles and dried in a vacuum oven at 55°C for 16h. The particles were cooled to room temperature and then crushed into fine powder with a mortar and pestle to obtain 149.0 g of white fine powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 21.8 VDMS groups and an average of 2.2 OH groups.
[0098] Synthesis of trimethylsilyl-vinyldimethylsilyl β-cyclodextrin CH74:
[0099] Beta-cyclodextrin (20.0g, 0.0176mol) is gradually added to a 500mL four-necked glass flask containing 250g (3.16mol) of anhydrous pyridine, while continuously stirring at 200rpm. The mixture is then stirred for 30 minutes to uniformly disperse cyclodextrin. A slightly yellow and translucent dispersion is produced without large distinguishable solid particles. 20.9g (0.129mol) of WACKER SILAZANE HMN, bis (trimethylsilyl) amine are loaded into a glass addition funnel, and 4.46g (0.0370mol) of chlorodimethylvinylsilane and 10.1g (0.0930mol) of chlorotrimethylsilane are loaded into another glass addition funnel together. Dropwise addition of bis (trimethylsilyl) amine lasts for about 2 minutes, and then dropwise addition of two kinds of chlorosilanes is started. Simultaneously, the silylating agent is continued to be added until both feeds are complete. Heat release is noted immediately after adding chlorosilanes. The reactor atmosphere was bubbled through a 3.7 wt. % solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that might be produced and drive the reaction to completion.
[0100] After the addition of the silylating agent was completed, the dispersion was stirred for another 65 minutes. The solvent was distilled off under vacuum until an off-white paste remained. The paste was then mixed with 375 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum until a waxy solid form. The waxy solid was dried in a vacuum oven at 70°C for 16 h to produce a solid mass, which was crushed into fine particles and dried for another 6 h under the same conditions. The particles were cooled to room temperature and then crushed with a mortar and pestle to obtain 37.8 g of a white fine powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was an average substituted cyclodextrin with 15.2 TMS, 1.4 VDMS and 4.4 OH groups.
[0101] Synthesis of Trimethylsilyl-Vinyldimethylsilyl γ-Cyclodextrin CH85
[0102] Under continuous stirring at 200 rpm, γ-cyclodextrin (20.0 g, 0.0154 mol) was gradually added to a 500 mL four-necked glass flask containing 200 g (2.53 mol) of anhydrous pyridine. The mixture was then stirred for 30 minutes to evenly disperse the cyclodextrin. A slightly yellow and translucent dispersion was produced with no large distinguishable solid particles.
[0103] 20.9 g (0.129 mol) of WACKER SILAZANE HMN (bis(trimethylsilyl)amine) was charged to a glass addition funnel and 3.91 g (0.0324 mol) of chlorodimethylvinylsilane and 10.6 g (0.0976 mol) of chlorotrimethylsilane were charged to another glass addition funnel. The bis(trimethylsilyl)amine was added dropwise for about 2 minutes and then the dropwise addition of the chlorosilane was started. The silylating agent was added dropwise simultaneously until both feeds were complete. An exotherm was noted immediately upon addition of the chlorosilane. The reactor atmosphere was bubbled through a 3.7 wt.% solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that may be produced and drive the reaction to completion.
[0104] After the addition of the silylating agent was completed, the dispersion was stirred for another 65 minutes. The solvent was distilled off under vacuum until an off-white paste remained. The paste was then mixed with 150 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture, and the clear, colorless filtrate was distilled under vacuum until a solid foam was formed. The solid foam was then crushed into fine particles and dried in a vacuum oven at 65° C. for 16 h. The particles were cooled to room temperature and then crushed into a fine powder with a mortar and pestle to obtain 38.5 g of white fine powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was an average substituted cyclodextrin with 18.5 TMS, 1.34 VDMS and 4.16 OH groups.
[0105] Synthesis of Trimethylsilyl-Vinyldimethylsilyl γ-Cyclodextrin CH60
[0106] Under continuous stirring at 200 rpm, gamma-cyclodextrin (20.0 g, 0.0154 mol) was gradually added to a 500 mL four-necked glass flask containing 200 g (2.53 mol) of anhydrous pyridine. The mixture was then stirred for 30 minutes to evenly disperse the cyclodextrin. A slightly yellow and translucent dispersion was produced with no large distinguishable solid particles. The mixture was cooled in an ice bath.
[0107] To the cooled, stirred mixture was slowly added 23.7 g (0.146 mol) of WACKERSILAZANE HMN, bis(trimethylsilyl)amine, using a glass addition funnel. Then 18.93 g (0.157 mol) of chlorodimethylvinylsilane was added dropwise using an addition funnel. An exotherm was noted immediately upon addition of the chlorosilane. The reactor atmosphere was bubbled through a 3.7 wt.% solution of hydrochloric acid in water and continuously replaced with a nitrogen blanket to remove any ammonia that may be produced and drive the reaction to completion.
[0108] After the addition of the silylating agent was completed, the ice bath was removed and the dispersion was stirred for an additional 65 minutes. The solvent was distilled off under vacuum until an off-white paste remained. The paste was then mixed with 100 mL of n-heptane using magnetic stirring for at least 30 minutes. The solid was filtered out from the mixture and the clear, colorless filtrate was distilled under vacuum until solid form. The solid was crushed and dried in a vacuum oven at 55 ° C for 16 h to obtain 39.0 g of a white, brittle solid. 1 HNMR, mass spectrometry and SEC confirmed that the product was a γ-cyclodextrin substituted with an average of 14.9 TMS, 8.1 VDMS and 1.0 OH groups.
[0109] Synthesis of Trimethylsilyl-Phenyldimethylsilyl β-Cyclodextrin CH86
[0110] Silyl-modified CD was synthesized by a procedure similar to CH74 using 18.0 g β-CD, 233.5 g pyridine, 9.4 g bis(trimethylsilyl)amine (HMN) and 39.8 g phenyldimethylchlorosilane. The purification step was slightly different from CH74. After the solvent was evaporated under vacuum, the residue was extracted with n-heptane and filtered. In a separatory funnel, the filtrate heptane solution was washed three times with an equal volume of methanol containing a few drops of saline. The heptane layer was collected from the bottom of the separatory funnel, the heptane was evaporated using a rotary evaporator and the residue was dried in a vacuum oven to obtain a solid, which was crushed into a white dry powder (38.0 g). 1 HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 7.9 TMS, 9.5 PhDMS (phenyldimethylsilyl) and an average of 3.6 OH groups.
[0111] Synthesis of Vinyldimethylsilyl-Phenyldimethylsilyl β-Cyclodextrin CH87
[0112] Silyl-modified CD was synthesized by a procedure similar to CH86 using 20.1 g β-CD, 234.0 g pyridine, 24.1 g bis(vinyldimethylsilyl)amine (VMN) and 22.1 g phenyldimethylsilyl chloride. 33.0 g of the product was obtained as a white dry powder. 1 HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 11.2 VDMS, 5.1 PhDMS and an average of 4.7 OH groups.
[0113] Synthesis of trimethylsilyl-phenylpropyldimethylsilyl β-cyclodextrin CH88 Silyl-modified CD was synthesized by a procedure similar to CH86 using 18.1 g β-CD, 233.2 g pyridine, 9.4 g bis(trimethylsilyl)amine (HMN) and 49.7 g 3-phenylpropyl)dimethylchlorosilane. The product was obtained as 45.6 g of a colorless viscous liquid. 1HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with 8.4 TMS, 7.8 PhPrDMS (dimethyl(3-phenylpropyl)silyl) and an average of 4.8 OH groups.
[0114] Synthesis of trimethylsilyl-vinyldimethylsilyl β-cyclodextrin CH77 with low silyl substitution:
[0115] Silyl-modified CD was synthesized by a procedure similar to CH74 using 25.0 g β-CD, 300.7 g pyridine, 18.7 g bis(trimethylsilyl)amine (HMN) and 11.2 g chlorodimethylvinylsilane. 41.0 g of white crisp powdery product was obtained. 1HNMR, mass spectrometry and SEC confirmed that the product was a substituted cyclodextrin with an average of 8.0 TMS, 3.2 VDMS and 9.8 OH groups. Therefore, in this silylated CD, an average of about 53% of the total OH groups are and an average of 47% of the OH groups are still underivatized. In this case, a relatively small relative amount of silanizing agent is used, resulting in a relatively low degree of silanization.
[0116] A summary of various examples of silylated CDs is shown in Table 1.
[0117] Table 1:
[0118]
[0119]
[0120] 1 Vinyldimethylsilyl
[0121] 2 Trimethylsilyl
[0122] 3 Dimethylphenylsilyl
[0123] 4 Dimethyl(3-phenylpropyl)silyl
[0124] Although only β- and γ-cyclodextrins are shown as examples, similar silylated cyclodextrins can also be prepared based on α-cyclodextrin.
[0125] Example of solubility of silylated cyclodextrin in silicone:
[0126] Silylated cyclodextrin CH60 (0.5 g) was mixed with 4.5 g of DM 5 (trimethylsilyl terminated linear polydimethylsiloxane with a viscosity of 5 mPa.s) was mixed to produce a 10 wt.% mixture. A clear, homogeneous, transparent solution was formed. Such a homogeneous mixture can also be formed by using a magnetic stirrer, an overhead stirrer, a SpeedmixerTM or similar mixing technology.
[0127] Similar experiments using silylated cyclodextrin CH70 showed solubility in DM5 at a 25 wt% level of CD. A clear, homogeneous, transparent solution was formed.
[0128] Comparative Solubility Example 1:
[0129] Native γ-CD without silanization modification The above experiment was repeated at W8. The resulting mixture was inhomogeneous and opaque with overall phase separation.
[0130] Comparative Solubility Example 2 (Solubility of Permethylated β-cyclodextrin):
[0131] Permethylated β-cyclodextrin (where all OH groups are derivatized to OMe groups, but which does not have any silyl modification) was purchased from Sigma Aldrich. 0.5 g of permethylated β-CD was mixed with 4.5 g of DM 5 in a vortex mixer to produce a 10 wt.% mixture. The mixture was inhomogeneous and opaque. This example shows that hydrocarbon (methyl in this case) substitution is not sufficient to make CD compatible with siloxanes, as the resulting mixture was inhomogeneous and opaque with overall phase separation.
[0132] Comparative Solubility Example 3 (Solubility of Silylated Cyclodextrin with Low Degree of Silylation):
[0133] Silylated β-cyclodextrin CH77 with a low number of silyl groups (average 7.95 TMS and 3.23 VDMS groups) was evaluated to examine solubility at 10 wt.% in DM 5. This CD was found to be insoluble in DM5.
[0134] Experimental Example for the preparation of silicone elastomer with silylated cyclodextrin:
[0135] Experimental Example of Elastomer CH95-70
[0136] 0.802 g (0.304 mmol) of CH70, dimethylvinylsilyl-β-cyclodextrin, and 52.0 g of a silhydride-terminated polydimethylsiloxane fluid having a viscosity of about 1000 mPa.s are placed in a suitable plastic cup with a lid along with a magnetic stirring bar. The cup is covered with nitrogen and then closed to maintain an inert atmosphere while stirring. The material is stirred until the cyclodextrin is completely dissolved. 22.9 g of a vinyl-terminated polydimethylsiloxane fluid having a viscosity of about 100,000 mPa.s is added to the solution and the contents of the plastic cup are manually mixed with a stirring bar. 0.0757 g of a platinum catalyst solution, tetramethyl divinyl disiloxane platinum complex (1% w / w Pt content) diluted in a vinyl-terminated polysiloxane is added to the mixture and manually mixed, followed by further mixing in FlackTek, Inc. Speedmixer™, model DAC 1100.2VAC, at 1250 rpm for 1 minute under vacuum (95 mbar pressure to degas the mixture).
[0137] The composition was then placed in a "plate and frame" mold lined with a suitable release liner. The composition and mold were placed in an oven preheated to 80°C for 1 hour to cure into a produced rubber plaque, approximately 6 inches by 6 inches by 0.072 inches. The cured elastomer sample was clear and colorless.
[0138] Experimental Example of Elastomer CH95-60
[0139] Elastomer slabs were produced from trimethylsilyl-vinyldimethylsilyl gamma-cyclodextrin CH60, a silicon hydride terminated polydimethylsiloxane fluid having a viscosity of about 1000 mPa.s, and a vinyl terminated polydimethylsiloxane fluid having a viscosity of about 100,000 mPa.s, and a platinum catalyst solution. The procedure was similar to CH95-70. The slabs were clear and colorless.
[0140] Experimental Example of Elastomer CH95-85
[0141] Elastomer slabs were produced from trimethylsilyl-vinyldimethylsilyl gamma-cyclodextrin CH85, a silane-terminated polydimethylsiloxane fluid having a viscosity of about 1000 mPa.s, and a vinyl-terminated polydimethylsiloxane fluid having a viscosity of about 100,000 mPa.s with a platinum catalyst solution. The procedure was similar to CH95-70. Table 2 shows examples of elastomers cured with silylated cyclodextrins.
[0142] Table 2
[0143]
[0144] *5 Tetramethyldivinyldisiloxane platinum complex diluted in vinyl terminated polysiloxane (1% w / w Pt content).
[0145] Comparison of cured elastomers incorporating silylated CDs with those incorporating non-silylated CDs:
[0146] Cured elastomer samples were prepared by using silanized cyclodextrin, dimethylvinylsilyl-trimethylsilyl-β-cyclodextrin CH68 having an average of 11.2 TMS, 5.4 VDMS and 4.4 OH groups, a silyl hydride terminated polydimethylsiloxane fluid having a viscosity of about 1000 mPa.s, and a vinyl terminated polydimethylsiloxane fluid having a viscosity of about 100,000 mPa.s with a platinum catalyst solution. The procedure was similar to CH95-70. The cured elastomer samples were prepared by using the same recipe but with natural β-cyclodextrin CH68. Another elastomer sample was prepared by replacing silyl β-cyclodextrin CH68 with W7. A third sample was prepared by the same method, but by replacing silyl β-cyclodextrin CH68 with permethylated β-cyclodextrin. The sample with silylated CD CH68 was transparent and homogeneous, while the two comparative samples were non-homogeneous, opaque, with large area separations.
[0147] Example of complexation of guest molecules by silylcyclodextrin
[0148] Silyl CDs are suitable for binding many guest molecules in their cavities. The CD-guest complexes can be formed by different methods commonly used for making cyclodextrin complexes, such as grinding, kneading, precipitation, solvent evaporation, freeze drying, etc. The complexation of the guest molecule can be verified by standard methods available in the literature, such as visual changes in appearance, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), nuclear magnetic resonance (NMR), infrared spectroscopy (IR), X-ray diffraction, etc.
[0149] Adamantane complexed with silyl CD:
[0150] The ability of silylated CD to complex adamantane as a guest molecule was shown by differential scanning calorimetry (DSC). Uncomplexed adamantane typically exhibits a thermal event corresponding to the enthalpy of the solid-solid (polymorph) transition from a face-centered cubic to a body-centered tetragonal lattice. This event occurs in a crystalline solid sample of adamantane, but will not occur if the individual adamantane molecules are isolated from each other due to individual incorporation into the CD cavity. Therefore, the absence of such a thermal event would indicate the inclusion of adamantane into the CD cavity.
[0151] Complexation of adamantane by CD itself:
[0152] Complexation was performed by mixing 1:1 molar ratio of silyl-β-CD VP31-2 having an average of 15.3 vinylsilyl groups and adamantane in a 50 wt % toluene solution at 60° C. for 1 hour. The complex (MG3) was isolated by removing the toluene using a vacuum oven.
[0153] Complexation between silyl-CD and adamantane in silicone elastomers:
[0154] Silyl-CD VP31-2 and adamantane were dissolved in toluene at a 1:1 molar ratio of 50 wt% (1:1 ratio of the total mass of CD and adamantane to the mass of toluene) and stirred at 60 °C for 1 h to form a complex. This solution was then added to SiH-terminated linear PDMS with an average viscosity of about 1000 mPa.s (1:1 SiH:vinyl molar ratio) and the mixture was stirred with a Speedmixer. TM (2000 rpm, 2 minutes) and mixed. Then platinum catalyst solution (same as mentioned in Table 1, 0.1% relative to the total mass of the mixture) was added to the mixture and the mixture was stirred again with Speedmixer. TM (2000 rpm, 2 min) and then the formulation was poured into an aluminum Petri dish and placed in an oven at 80° C. for 1 h. A clear, colorless and homogeneous elastomer (MG3-1) was obtained.
[0155] The formation of the complex was confirmed by DSC experiments. DSC was performed on native adamantane, the product from the 1:1 CD:adamantane complexation scheme (MG3), and the product from the complexation scheme of silyl-CD and adamantane in a silicone elastomer product (MG3-1). The results are shown in Figure 1 (a) Silyl-CD VP31-2, (b) adamantane, (c) elastomer MG3-1 containing silyl-CD-adamantane complex, (d) 1:1 mixture of VP31-2 and adamantane without complexation scheme, (e) product (MG3) from the complexation scheme with 1:1 VP31-2 and adamantane.
[0156] In the experiment, a solid-solid transition was observed for adamantane at about -59°C (thermogram b). This thermal event from adamantane also does not appear in thermogram e (product from complexation experiment with 1:1 CD:adamantane) nor in c (elastomer incorporating product MG3 from CD and adamantane complexation protocol). Since MG3 is the starting material for elastomer MG3-1, the results show that adamantane was successfully complexed following the complexation protocol and that the complex even remained intact in the elastomer.
[0157] To demonstrate the use of this method to detect uncomplexed adamantane, a physical mixture (without a complexation step) was prepared with silyl-CD VP31-2 and adamantane in a 1:1 ratio (DSC results are shown in thermogram d). Figure 4 It is clear from the Figure that these amounts of uncomplexed adamantane can be detected using this method (characteristic peaks observed for thermogram d).
[0158] Example of complexation between silyl-CD and geraniol
[0159] Trimethylsilyl-β-cyclodextrin CH62 (1.416 g, 0.59 mmol) was weighed and placed in a mortar, and then geraniol (0.09100 g, 0.59 mmol) was added to TMS-β-CD and ground with a pestle for 15 minutes. The mixture was checked for separated solid pieces and grinding was continued until no pieces were observed. Complexation was confirmed by DSC analysis ( Figure 2 ).
[0160] The endothermic peak of pure geraniol at about 240° C. indicates its boiling point. The disappearance of the peak confirms the complex formation of the CD-geraniol combination.
[0161] Similar experiments with other active substances were performed and complex formation was confirmed by DSC.
[0162] The DSC thermogram of a 2:1 combination of α-tocopherol with VDMS-TMS-β-CD MG 15 and VDMS-TMS-γ-CD CH60 is shown in Figure 3 middle.
[0163] The graph of pure α-tocopherol shows a glass transition temperature (Tg) of about −61° C. The complete disappearance of this peak for both combinations with TMS-β-CD MG 15 or TMS-γ-CD CH60 confirms that both CDs form a complex with α-tocopherol.
[0164] Example of complexation between silyl-CD and salicylic acid:
[0165] Trimethylsilyl-β-cyclodextrin CH62 (1.415 g, 0.59 mmol) was weighed and placed in a mortar, and then salicylic acid (0.0815 g, 0.59 mmol) was added to the TMS-β-CD and ground with a pestle for 15 minutes. Approximately 5-7 mL of ethanol was added to the mixture, and grinding was continued for another 15 minutes. The mixture was placed in a small flask and the ethanol was evaporated by placing the mixture in an oven at 90°C. Composites were confirmed by optical microscopy analysis.
[0166] The microscopic images showed different crystalline phases of the composites, which were different from the original crystalline phases of the amorphous powder mixtures of salicylic acid or physical blends.
[0167] Various examples for the complexation between silyl-CD and various guest molecules are shown in Table 3.
[0168] Table 3
[0169]
[0170] Complex formation offers advantages for practical applications of these guest molecules, many of which are pharmaceutical or cosmetic actives. For example, complexation slows down the evaporation of the active, allowing the active to last longer. This was confirmed by thermogravimetric analysis (TGA). The results of thermogravimetric analysis of pure geraniol and its 1:1 complex with trimethylsilyl-β-cyclodextrin CH62 are shown in Figure 4 middle.
[0171] The complex with TMS-β-CD CH62 contains about 6 wt.% geraniol. Pure geraniol starts to evaporate at about 75°C and evaporates completely at about 225°C. In the composite, evaporation does not begin until about 110°C and continues slowly until about 300°C. Therefore, the complexation with silyl-CD slows down the loss of geraniol.
[0172] exist Figure 5 In Figure 5, the TGA thermograms showed similar observations for the complexation between silyl-CD MG 15 and α-pinene 1:1 compared to pure α-pinene.
[0173] As can be seen from the TGA results, the onset of weight loss of pure pinene due to evaporation begins at about room temperature (<30° C.). For the pinene-CD combination, the onset increases significantly to about 135° C. Pure pinene evaporates completely at 140° C., but complete evaporation of pinene from the complex requires temperatures as high as about 200° C.
[0174] The complexes formed between the silanized CD and various guest molecules can be incorporated into the elastomer and produce transparent and / or homogeneous formulations for the silicone rubber compositions of the present invention and the cured silicone products of the present invention.
[0175] The cured silicone elastomer product not of the present invention incorporating a complex between native β-CD (unsilanized) and geraniol is unclear.
[0176] In some cases, incorporating silyl-CD into the elastomer curing composition provides a practical advantage in obtaining a good cure. Some actives can interfere with the catalyst (e.g., platinum) used for curing. Encapsulating the active in silyl-CD prevents the active from poisoning the catalyst. Such an example using salicylic acid as the active is provided below:
[0177] A cured elastomer / CD / salicylic acid sample (VP178-3) containing a 1:1 molar ratio of salicylic acid to silyl-CD was prepared using the following method:
[0178] SiH terminated linear silicone (1.449 g) with an approximate viscosity of 1000 mPa.s of approximate formula MHD220MH and SiH terminated and pendant SiH containing silicone (0.045 g) with an approximate viscosity of 165 mPa.s of approximate formula MHD95.5DH9.6MH were mixed using SpeedmixerTM. The inclusion complex between silyl-CD CH62 and salicylic acid prepared by the above method (1.057 g, 1:1 molar ratio between CD: salicylic acid) was added and further mixed with the siloxane component until the complex was well dispersed. Vinyl terminated linear silicone with a viscosity of about 1000 mPa.s (1.981 g) was added and further mixed. Platinum catalyst solution (containing 1% Pt) (0.078 g) was added and the mixture was further mixed. The mixture was placed in an oven at 120°C for 1 hour to obtain a cured elastomer.
[0179] A control sample (VP178-2) not containing any silylated CD was prepared using the following method: SiH terminated linear silicone (2.900 g) with an approximate viscosity of 1000 mPa.s of approximate formula MHD220MH and SiH terminated and pendant SiH containing silicone (0.090 g) with an approximate viscosity of 165 mPa.s of approximate formula MHD95.5DH9.6MH were mixed using a SpeedmixerTM. Salicylic acid (0.088 g) was added and further mixed until well dispersed. Vinyl terminated linear silicone (3.963 g) with a viscosity of approximately 1000 mPa.s was added and further mixed. Platinum catalyst solution (containing 1% Pt) (0.078 g) was added and the mixture was further mixed. The mixture was placed in an oven at 120°C for 1 h, however, the mixture was liquid and no curing occurred.
[0180] Example of using silyl-modified CD for controlled release of geraniol from elastomer:
[0181] A cured elastomer / CD / geraniol sample (VP141-2-1) containing a 10:1 molar ratio of geraniol to CD was prepared by using the following procedure: Trimethylsilyl-β-cyclodextrin CH62 (1.41 g, 0.59 mmol) and geraniol (0.90 g, 5.9 mmol) were added to a plastic cup and mixed using a Speedmixer™ at 2000 rpm for 2 minutes (mixing was repeated 2-3 times). The mixture looked almost homogeneous. SiH terminated linear silicone (13.95 g) with an approximate formula of MHD220MH and an approximate viscosity of 1000 mPa.s, SiH terminated and pendant SiH containing silicone (0.71 g) with an approximate formula of MHD95.5DH9.6MH and an approximate viscosity of 165 mPa.s, vinyl terminated linear silicone (22.31 g) with an approximate viscosity of 1000 mPa.s and platinum catalyst solution (0.078 g) were added to the cup and mixed at 2000 rpm for 2 minutes (× 3-4 times) using SpeedmixerTM. The resulting clear and colorless mixture was left in a tightly closed cup for 24-36 hours to cure at room temperature to obtain a cured elastomer sample.
[0182] A control sample (VP141-2-0) not containing any silanized CD was prepared using the following method: SiH terminated linear silicone (14.13 g) with an approximate chemical formula of MHD220MH and an approximate viscosity of 1000 mPa.s, SiH terminated and pendant SiH containing silicone (0.77 g) with an approximate chemical formula of MHD95.5DH9.6MH and an approximate viscosity of 165 mPa.s, and geraniol (0.93 g) were weighed and placed in a plastic cup and mixed using a Speedmixer™ at 2000 rpm for 2 minutes (mixing was repeated twice). Then, a vinyl terminated linear silicone with a viscosity of about 1000 mPa.s (23.09 g) and a platinum catalyst solution (0.075 g) were added to the cup and mixed using a Speedmixer™ at 2000 rpm for 2 minutes (mixing was repeated 2-3 times). The resulting clear, colorless mixture was left in a tightly closed cup for 24-36 hours to cure at room temperature to obtain a cured elastomer sample.
[0183] The release of geraniol from two samples (sample containing silanized CD = invention and control = not invention) was studied by heating the samples at 60°C for 150 h in a Thermo Scientific Heratherm oven and measuring the weight loss. The release curve showing the residual amount of geraniol is Figure 6 Shown in.
[0184] Initially, a rapid release of geraniol from both samples was observed due to the loss of excess uncomplexed geraniol. It should be noted that pure geraniol evaporates completely in only a few hours. The control elastomer sample (VP141-2-0) releases all of the geraniol within 72 hours, while in the elastomer / CD sample, about 6% of the geraniol still remains at this point. The remaining amount of geraniol corresponds to the amount present in a 1:1 complex with CD, and a slower release is observed thereafter.
[0185] Geraniol was completely released from the elastomer / CD sample after 140 hours. Thus, the sample VP141-2-1 containing geraniol / CD extended the release up to 140 hours.
[0186] Example of use of silyl-modified CD for controlled release of α-tocopherol from elastomers:
[0187] First, an inclusion complex is prepared between trimethylsilyl-vinyldimethylsilyl-β-cyclodextrin CH74 and α-tocopherol. An excess of tocopherol (20: 1 molar ratio between tocopherol and CD) is used. Trimethoxysilyl-vinyldimethylsilyl-β-cyclodextrin (CH74, 0.608 g, 0.259 mmol) is weighed and placed in a mortar and then thoroughly ground before adding tocopherol. Tocopherol (2.229 g, 5.176 mmol) is added to silyl-CD (CH74) and ground with a pestle for 15 minutes. The mixture is a pale yellow semisolid. Check for separated solid pieces and continue grinding until no pieces are observed.
[0188] The elastomer / CD / tocopherol (20:1 tocopherol:CD molar ratio) matrix (VP142-1) was prepared using the following procedure:
[0189] 2.837 g of the prepared tocopherol-CD combination (which contains the complex and excess tocopherol (20:1 tocopherol:CD by mole) was placed in a plastic cup, and a SiH-terminated linear silicone with an approximate chemical formula of MHD220MH and an approximate viscosity of 1000 mPa.s (12.00 g) was added. The cup with the mixture was mixed in a SpeedmixerTM at 2000 rpm (×3 times) for 2 minutes until a uniform mixture was formed. A vinyl-terminated linear silicone with a viscosity of about 1000 mPa.s (8.194 g) and a platinum catalyst solution (0.0230 g) were added and mixed at 2000 rpm for 2 minutes (×2 times) using a SpeedmixerTM. The resulting mixture was used to prepare a down-drawn film (15 mil thickness) on a MYLARTM plate. The film was placed in a preheated oven (80° C.) and cured for 2 h to obtain a cured elastomeric film.
[0190] A control elastomer sample (VP142-0) not containing any silylated CD was prepared using the following method: SiH terminated linear silicone (10.00 g) of approximate formula MHD220MH and viscosity of about 1000 mPa.s, SiH terminated and pendant SiH containing silicone (0.200 g) of approximate formula MHD95.5DH9.6MH and viscosity of 165 mPa.s, and α-tocopherol (2.409 g) were weighed and placed in a plastic cup and mixed at 2000 rpm (×4) for 2 minutes using a Speedmixer™. Then, vinyl terminated linear silicone with a viscosity of about 1000 mPa.s (12.27 g) and platinum catalyst solution (0.0249 g) were added to the cup and rapidly mixed at 2000 rpm (×4) for 2 minutes. This resulted in a viscous, milky, and slightly yellow mixture. The resulting mixture was used to prepare a down drawn film (15 mil) on MYLARTM sheet.The film was placed in a preheated oven (80°C) and allowed to cure for 2 h.
[0191] The release of tocopherol from two samples, elastomer / CD (VP142-1) and control (VP142-0), was studied in the following manner:
[0192] Use the biopsy punch of 1cm diameter to punch out samples from these solidified films, weigh them and record their accurate mass.Each sample is placed in a sealed glass bottle, and the bottle is filled with the isopropyl alcohol (IPA) of 16.00g.Bottle (each equipped with sample and IPA) is placed on an orbital oscillator.The tocopherol concentration in the IPA solution is measured by extracting aliquots at different time intervals and analyzing by HPLC.Calculate the residual tocopherol wt.% remaining in each sample subsequently.
[0193] exist Figure 7 The release curves of α-tocopherol from a silicone matrix are shown for the elastomer-CD-tocopherol sample VP142-1 (solid line) = according to the invention and the control VP-142-0 (dashed line) = not according to the invention, showing the remaining amount of tocopherol at different time intervals.
[0194] An initial rapid release due to excess tocopherol was observed from both samples. The subsequent release was much faster than the control sample (after 95 h, only about 6% tocopherol remained). For the elastomer sample containing silyl-CD, a slower (more prolonged) release of tocopherol was observed (after 150 h, about 35% tocopherol still remained).
Claims
1. A curable silicone rubber composition comprising: - 20 wt% to 99.9 wt% of a silicone matrix, and - 0.1 wt% to 80 wt% of at least one cyclodextrin (CD) modified by a silylation reaction to contain a silyl group of formula (1) -(OSi(R 1 )3) x (1) The condition is R 1 are independently identical or different alkyl, alkylene, aryl or alkyl-substituted aryl groups, carbonyl; and x is a number from 1 to 96; - 0 to 50 wt % of at least one active substance (= guest molecule), Based on the total silicone rubber composition, The proviso is that all components always add up to 100 wt%.
2. The curable silicone rubber composition according to claim 1, provided that the curable silicone rubber composition is an addition-curable silicone composition.
3. The curable silicone rubber composition according to claim 1 or 2, wherein R 1 Selected from methyl, ethyl, vinyl and phenyl.
4. The curable silicone rubber composition according to claims 1 to 3, provided that x is a number from 1 to 30.
5. The curable silicone rubber composition according to claims 1 to 3, with the proviso that the guest molecule is selected from the group comprising drugs, pharmaceutical products, cosmetic or personal care or health actives, biocides, insecticides, fungicides, herbicides, pheromones, fragrances, flavorings, pigments, pharmaceutically active compounds, natural or other oils, antigens, active compounds for antistatic finishes or flame retardant finishes, stabilizers (UV), dyes, odor-causing molecules or a combination of two or more.
6. A process for preparing the curable silicone rubber composition of the invention according to claims 1 to 5 by mixing all compounds by standard mixing techniques at room temperature or by heating.
7. A silicone product obtained by filling the curable silicone rubber composition according to claims 1 to 5 into a structure or applying it onto a surface and then curing it.
8. Use of the silicone product according to claim 7, when it contains actives, for the controlled, delayed or triggered release of such actives.
9. Use of the silicone product according to claim 8 in pharmaceutical applications, cosmetic applications, personal care applications, health applications, room fragrance applications, biocide applications, insecticide applications, fungicide applications, herbicide applications, textile applications.
10. Use of a silicone product according to claim 6 when it contains no actives in applications for capturing undesirable agents.
